Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice

被引:91
作者
Koedoot, CG
de Haan, RJ
Stiggelbout, AM
Stalmeier, PFM
de Graeff, A
Bakker, PJM
de Haes, JCJM
机构
[1] Acad Med Ctr, Dept Psychol Med, NL-1100 DE Amsterdam, Netherlands
[2] Acad Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[3] Leiden Univ, Dept Clin Decis Making, Med Ctr, Leiden, Netherlands
[4] Univ Med Ctr, Dept Internal Med, Utrecht, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
关键词
palliative chemotherapy; best supportive care; decision-making; treatment preference; treatment choice;
D O I
10.1038/sj.bjc.6601445
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In palliative cancer treatment, the choice between palliative chemotherapy and best supportive care may be difficult. In the decision-making process, giving information as well as patients values and preferences become important issues. Patients, however, may have a treatment preference before they even meet their medical oncologist. An insight into the patient's decision-making process can support clinicians having to inform their patients. Patients (n=207) with metastatic cancer, aged 18 years or older, able to speak Dutch, for whom palliative chemotherapy was a treatment option, were eligible for the study. We assessed the following before they consulted their medical oncologist: (1) socio-demographic characteristics, (2) disease-related variables, (3) quality-of-life indices, (4) attitudes and (5) preferences for treatment, information and participation in decision-making. The actual treatment decision, assessed after it had been made, was the main study outcome. Of 207 eligible patients, 140 patients (68%) participated in the study. At baseline, 68% preferred to undergo chemotherapy rather than wait watchfully. Eventually, 78% chose chemotherapy. Treatment preference (odds ratio (OR) = 10.3, confidence interval (CI) 2.8-38.0) and a deferring style of decision-making (OR=4.9, CI 1.4-17.2) best predicted the actual treatment choice. Treatment preference (total explained variance = 38.2%) was predicted, in turn, by patients striving for length of life (29.5%), less striving for quality of life (6.1%) and experienced control over the cause of disease (2.6%). Patients actual treatment choice was most strongly predicted by their preconsultation treatment preference. Since treatment preference is positively explained by striving for length of life, and negatively by striving for quality of life, it is questionable whether the purpose of palliative treatment is made clear. This, paradoxically, emphasises the need for further attention to the process of information giving and shared decision-making.
引用
收藏
页码:2219 / 2226
页数:8
相关论文
共 51 条
[1]  
[Anonymous], 1995, Michigan Assessment of Decision Style (MADS)
[2]   Normal blood glucose and coronary risk - Dose response effect seems consistent throughout the glycaemic continuum [J].
Barrett-Connor, E ;
Wingard, DL .
BRITISH MEDICAL JOURNAL, 2001, 322 (7277) :5-6
[3]   INFORMATION AND DECISION-MAKING PREFERENCES OF HOSPITALIZED ADULT CANCER-PATIENTS [J].
BLANCHARD, CG ;
LABRECQUE, MS ;
RUCKDESCHEL, JC ;
BLANCHARD, EB .
SOCIAL SCIENCE & MEDICINE, 1988, 27 (11) :1139-1145
[4]   Trading treatment toxicity for survival in locally advanced non-small cell lung cancer [J].
Brundage, MD ;
Davidson, JR ;
Mackillop, WJ .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :330-340
[5]   INFORMATION AND PARTICIPATION PREFERENCES AMONG CANCER-PATIENTS [J].
CASSILETH, BR ;
ZUPKIS, RV ;
SUTTONSMITH, K ;
MARCH, V .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (06) :832-836
[6]   Doing nothing is no choice: lay constructions of treatment decision-making among women with early-stage breast cancer [J].
Charles, C ;
Redko, C ;
Whelan, T ;
Gafni, A ;
Reyno, L .
SOCIOLOGY OF HEALTH & ILLNESS, 1998, 20 (01) :71-95
[7]   Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model [J].
Charles, C ;
Gafni, A ;
Whelan, T .
SOCIAL SCIENCE & MEDICINE, 1999, 49 (05) :651-661
[8]   Patient centered decision making in palliative cancer treatment: a world of paradoxes [J].
de Haes, H ;
Koedoot, N .
PATIENT EDUCATION AND COUNSELING, 2003, 50 (01) :43-49
[9]   DECISION-MAKING DURING SERIOUS ILLNESS - WHAT ROLE DO PATIENTS REALLY WANT TO PLAY [J].
DEGNER, LF ;
SLOAN, JA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (09) :941-950
[10]   MEASURING PSYCHOLOGICAL AND PHYSICAL DISTRESS IN CANCER-PATIENTS - STRUCTURE AND APPLICATION OF THE ROTTERDAM-SYMPTOM-CHECKLIST [J].
DEHAES, JCJM ;
VANKNIPPENBERG, FCE ;
NEIJT, JP .
BRITISH JOURNAL OF CANCER, 1990, 62 (06) :1034-1038